Mostrar el registro sencillo del ítem

dc.contributor.authorBarrios del Pino, Yvelise 
dc.contributor.authorYáñez, Rosa
dc.contributor.authorRuiz, Elena
dc.contributor.authorCabrera, Rafael
dc.contributor.authorDı´az-Espada, Fernando
dc.date.accessioned2023-12-19T21:07:26Z
dc.date.available2023-12-19T21:07:26Z
dc.date.issued2008
dc.identifier.issn1524-9557
dc.identifier.urihttp://riull.ull.es/xmlui/handle/915/34903
dc.description.abstractA specific immune response against the individual idiotypic determinants of clonal immunoglobulins can be elicited in patients with B-cell malignancies. We analyze the clinical outcome and the presence of tumor cells in the blood of 8 patients with follicular lymphoma, vaccinated with autologous idiotype protein from their lymphoma cells. After a median follow-up of 90 months (range: 54 to 128), all patients, except 1, remain in complete clinical remission and 5 are in complete molecular remission. Our results suggest that idiotype vaccination induces long-lasting clinical and molecular remissions and constitutes a potential curative treatment in follicular lymphoma patients. © 2008 Lippincott Williams & Wilkins, Inc.en
dc.format.mimetypeapplication/pdf
dc.language.isoen
dc.relation.ispartofseriesJournal of Immunotherapy, 2008 v.31 n. 3, 310-312
dc.rightsLicencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/deed.es_ES
dc.titleAnti-idiotypic Immunotherapy in Follicular Lymphoma Patients
dc.typeinfo:eu-repo/semantics/article
dc.identifier.doihttps://doi.org/10.1097/CJI.0B013E31816A8116
dc.subject.keywordLymphoma immunotherapy
dc.subject.keywordIdiotypic vaccination
dc.subject.keywordTumor vaccines


Ficheros en el ítem

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)
Excepto si se señala otra cosa, la licencia del ítem se describe como Licencia Creative Commons (Reconocimiento-No comercial-Sin obras derivadas 4.0 Internacional)